Le Lézard
Classified in: Health
Subject: SVY

Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026


NEW YORK, June 13, 2018 /PRNewswire/ -- Depression Drugs Market - Overview

This report analyzes the global depression drugs market in terms of its current and future scenario. Increase in prevalence of major depression disorders, rise in government initiatives in creating awareness about depression drugs, and growth in geriatric population across the world are expected to drive the depression drugs market during the forecast period.

Read the full report: https://www.reportlinker.com/p05439363

The report on the global depression drugs market comprises an elaborate executive summary, including a market snapshot that provides information on various segments.It also provides information and data analysis of the global market with respect to its segments based on drug class, disease type, distribution channel, and geography.

A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section.Additionally, the section comprises product pipeline analysis to help understand the scope of the market.

The section also provides market share analysis in terms of segments, geography and key players, thus presenting a thorough analysis of the overall competitive scenario in the global depression drugs market.

The global depression drugs market has been classified on the basis of drug class, disease type, distribution channel, and region.Based on drug class, the market has been categorized into atypical antipsychotics, serotonin?norepinephrine reuptake inhibitor, selective serotonin reuptake inhibitor, central nervous system (CNS) stimulant, and others.

In terms of disease type, the market has been classified into major depressive disorder, schizophrenia and bipolar I disorder, selective serotonin reuptake inhibitor induced, and others. Based on distribution channel, the market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the global depression drugs market has been categorized into five major regions and key countries in those regions: North America (U.S. and Canada), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Israel, GCC, and Rest of Middle East & Africa).

The report also profiles major players operating in the global depression drugs market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company, Pfizer Inc., AstraZeneca, Allergan USA, Inc., Novartis AG, GlaxoSmithKline, and Takeda Pharmaceutical Company Ltd.

The global depression drugs market has been segmented as below:

Global Depression Drugs Market, by Drug Class
Atypical antipsychotics
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
CNS stimulants
Others (Benzodiazepines and miscellaneous antidepressants)

Global Depression Drugs Market, by Disease Type
Major depressive disorders
Schizophrenia and bipolar I disorder (manic depression)
SSRI induced
Others (attention deficit hyperactivity disorder and anxiety disorders)

Global Depression Drugs Market, by Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies

Global Depression Drugs Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

Read the full report: https://www.reportlinker.com/p05439363

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 08:35
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company...

at 08:34
Hire Velocity, a leading provider of recruitment process outsourcing (RPO) and professional search solutions, announced the launch of Hire Health, a healthcare-focused human capital solutions firm. The launch of Hire Health reinforces Hire Velocity's...

at 08:31
RTI International, a nonprofit research institute, and Nested Knowledge, a platform for AI-driven evidence synthesis, systematic literature review and meta-analysis, formally announce a strategic collaboration between the two organizations. The...

at 08:30
According to a new report published by Dialogue Health Technologies Inc., Canada's leading health and wellness virtual care platform, Canadians' overall well-being is at a low point as they struggle with lifestyle challenges around sleep and physical...

at 08:30
Selecting appropriate sites is one of the most crucial determinants of study success, yet efficient clinical trial site selection continues to be a prominent industry-wide...

at 08:30
In the news release, Nanalysis Announces Full Year 2023 Conference Call, issued 11-Apr-2024 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the Hosting Call and European Q&A Session date mentioned should read "Monday, April...



News published on and distributed by: